Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival.
about
Study of cardiovascular disease biomarkers among tobacco consumers, part 1: biomarkers of exposure.Knowledge and Perceptions about Nicotine, Nicotine Replacement Therapies and Electronic Cigarettes among Healthcare Professionals in Greece.Adult interest in using a hypothetical modified risk tobacco product: findings from Wave 1 of the Population Assessment of Tobacco and Health Study (2013-2014).Smokeless tobacco (snus) is associated with an increased risk of type 2 diabetes: results from five pooled cohorts.Use of Swedish smokeless tobacco (snus) and the risk of Type 2 diabetes and latent autoimmune diabetes of adulthood (LADA).Snus use during the life-course and risk of the metabolic syndrome and its components.The Swedish National March Cohort.Trends and Factors Related to Smokeless Tobacco Use in the United States.Comprehensive review of cardiovascular toxicity of drugs and related agents.Associations between snus use, body mass index and general health in a cross-sectional population-based sample of women.An investigation on the use of snus and its association with respiratory and sleep-related symptoms: a cross-sectional population study.Brief exposure to Swedish snus causes divergent vascular responses in healthy male and female volunteers.Smokeless tobacco use and circulatory disease risk: a systematic review and meta-analysisA systematic review on association between smokeless tobacco & cardiovascular diseases
P2860
Q35834322-51F2EF35-B54D-4D4E-B57E-08BA3C424E20Q36938050-876F0EE5-B69A-4386-B6CA-FC4A36DB2A5DQ38666888-163E99AE-4A60-4E86-A3DA-AB3C24A8B60AQ38977509-B87FA2EB-4E7C-45BB-BC6C-9ABE34C9C981Q39648112-D40614A6-3C7F-4680-996B-000C0CFF990EQ40136623-C4F5151B-042C-474A-BDCA-CC3A9CA4727DQ40573140-51A8D4C8-ADBE-4EC5-BB86-1E65D3DDDF8EQ40843170-05A203B5-4F36-4993-BD4A-779C880053A0Q47556269-05FA90D1-F795-45FD-BB5A-D1DAAD54F336Q47563425-BFAC8042-1B7E-47BE-B90A-67BF3B4ED827Q47726212-F8417D1B-39AE-48F5-ABD7-F35D7A558A08Q52580574-848F4EA4-E407-4B59-8DD7-947809E14B5BQ57921824-E0DD16B6-7C11-472E-AF0E-55C02475EA16Q57938337-F2D9AB43-8BD5-40F4-9E2C-F0B863AB40F6
P2860
Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Snus (Swedish smokeless tobacc ...... ses of incidence and survival.
@ast
Snus (Swedish smokeless tobacc ...... ses of incidence and survival.
@en
type
label
Snus (Swedish smokeless tobacc ...... ses of incidence and survival.
@ast
Snus (Swedish smokeless tobacc ...... ses of incidence and survival.
@en
prefLabel
Snus (Swedish smokeless tobacc ...... ses of incidence and survival.
@ast
Snus (Swedish smokeless tobacc ...... ses of incidence and survival.
@en
P2093
P2860
P50
P356
P1476
Snus (Swedish smokeless tobacc ...... ses of incidence and survival.
@en
P2093
J Hallqvist
J-H Jansson
M R Galanti
M-P Hergens
N L Pedersen
P Fredlund
P-O Ostergren
R Bellocco
P2860
P356
10.1111/JOIM.12219
P407
P577
2014-03-29T00:00:00Z